German CRO opens U.K. subsidiary

Thursday, May 26, 2011 02:37 PM

Accovion, a European CRO based in Eschborn, Germany, has extended its reach into what it terms a “key strategic territory” with a new subsidiary, Accovion Ltd., in Windsor, U.K., according to PharmaTimes.

Not only has the U.K. always been a key strategic territory for the company, but also Accovion’s expanding regulatory portfolio and growing involvement in device pharmacovigilance and health economics meant it was “imperative for us to be firmly implanted in London,” said chief operating officer Ivana Waller. 

The company was already established at two locations in Germany as well as in the Czech Republic, Poland, Romania and Russia. The Czech and Russian subsidiaries opened last December.

The U.K. subsidiary, which will be headed up by newly appointed managing director Carl Naraynassamy, “consolidates our presence in Europe and affords us a sure platform to access the considerable local clinical research talent and respond even better to our clients' growing needs,” said Waller.

Accovion’s strategic plan for 2011 includes formalizing activities in a number of other European countries by setting up additional subsidiaries.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs